Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2024 is 21.91% vs 64.04% in Mar 2023
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2024 is 19.62% vs 20.38% in Mar 2023
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2024 is 18.96% vs 41.64% in Mar 2023
Compare Balance Sheet Results of Fredun Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
4.70
32.77
-28.07
-85.66%
Share Warrants & Outstandings
Total Reserve
115.20
18.64
96.56
518.03%
Shareholder's Funds
121.47
59.27
62.20
104.94%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
12.80
160.29
-147.49
-92.01%
Secured Loans
12.80
160.29
-147.49
-92.01%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
4.14
-7.04
11.18
158.81%
Other Long Term Liabilities
0.00
2.29
-2.29
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
2.37
17.45
-15.08
-86.42%
Total Non-Current Liabilities
19.30
173.00
-153.70
-88.84%
Current Liabilities
Trade Payables
62.95
138.46
-75.51
-54.54%
Other Current Liabilities
11.17
20.66
-9.49
-45.93%
Short Term Borrowings
92.71
12.94
79.77
616.46%
Short Term Provisions
0.00
2.56
-2.56
-100.00%
Total Current Liabilities
166.83
174.61
-7.78
-4.46%
Total Liabilities
307.60
406.88
-99.28
-24.40%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
62.98
271.51
-208.53
-76.80%
Less: Accumulated Depreciation
16.40
81.60
-65.20
-79.90%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
46.57
189.92
-143.35
-75.48%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
5.38
-5.38
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.02
-0.02
-100.00%
Long Term Loans & Advances
3.36
5.90
-2.54
-43.05%
Other Non Current Assets
0.46
1.53
-1.07
-69.93%
Total Non-Current Assets
50.40
213.44
-163.04
-76.39%
Current Assets Loans & Advances
Current Investments
0.81
0.13
0.68
523.08%
Inventories
175.00
37.68
137.32
364.44%
Sundry Debtors
64.85
114.16
-49.31
-43.19%
Cash and Bank
1.35
12.83
-11.48
-89.48%
Other Current Assets
1.44
21.47
-20.03
-93.29%
Short Term Loans and Advances
13.76
7.18
6.58
91.64%
Total Current Assets
257.20
193.44
63.76
32.96%
Net Current Assets (Including Current Investments)
90.37
18.83
71.54
379.93%
Total Current Assets Excluding Current Investments
256.39
193.31
63.08
32.63%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
307.60
406.88
-99.28
-24.40%
Contingent Liabilities
0.00
65.85
-65.85
-100.00%
Total Debt
105.51
173.23
-67.72
-39.09%
Book Value per share (adjusted)
255.15
16.26
238.89
1,469.19%
Annual - Borrowings
Borrowings 105.51 Cr
in Mar 2024Figures in Cr
YoY Growth in year ended Mar 2024 is 21.91% vs 64.04% in Mar 2023
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 46.57 Cr
in Mar 2024Figures in Cr
YoY Growth in year ended Mar 2024 is 19.62% vs 20.38% in Mar 2023
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 257.20 Cr
in Mar 2024Figures in Cr
YoY Growth in year ended Mar 2024 is 18.96% vs 41.64% in Mar 2023






